Literature DB >> 16959687

C-reactive protein in hypertensive disorders in pregnancy.

Delia M Paternoster1, Sara Fantinato, Andrea Stella, Kimta Ngaradoumbe Nanhornguè, Massimo Milani, Mario Plebani, Umberto Nicolini, Antonio Girolami.   

Abstract

Hypertension is the most frequent medical complication of pregnancy. A recent report demonstrates the flogistic pathogenesis of pregnancy-induced hypertension. Because C-reactive protein (CRP) is a marker of inflammation, it can be used in the differential diagnosis of hypertensive disorders of pregnancy. A total of 322 pregnant women at 24 to 32 weeks' gestation were enrolled. The control group (A) comprised 190 women. Sixty-three women had preeclampsia (PE, group B), 31 women presented transient hypertension (TH, group C), 19 had HELLP syndrome (HS, group D) and 19 had chronic hypertension (CH, group E). CRP serum concentrations were significantly higher in groups B, C, and D in comparison with the group A. In the whole population, systolic and diastolic pressure value inversely correlate with weight at delivery and weeks of gestation at delivery. CPR levels in patients with PE and HS inversely correlate with birth weight and gestational week at delivery. Normal plasma levels of CRP may be an important marker of differential diagnosis between TH and CH. In TH, PE, and HS, CRP levels were higher than in the control and CH groups, suggesting that inflammation may be the common pathogenetic cause of TH and PE. Finally CRP levels in preeclampsia are believed to correlate with preeclamptic process severity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959687     DOI: 10.1177/1076029606291382

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN: 1076-0296            Impact factor:   2.389


  14 in total

1.  Pre-eclampsia is an inflammatory disorder.

Authors:  Jecko V Thachil
Journal:  BMJ       Date:  2007-11-24

2.  Does C-reactive protein predict recurrent preeclampsia?

Authors:  Hilary S Gammill; Robert W Powers; Rebecca G Clifton; J Peter Van Dorsten; Mark A Klebanoff; Marshall D Lindheimer; Baha Sibai; Mark B Landon; Menachem Miodovnik; Mitchell Dombrowski
Journal:  Hypertens Pregnancy       Date:  2010       Impact factor: 2.108

Review 3.  Association between maternal infections and preeclampsia: a systematic review of epidemiologic studies.

Authors:  Luis O Rustveld; Sheryl F Kelsey; Ravi Sharma
Journal:  Matern Child Health J       Date:  2007-06-19

4.  Diagnosis and Treatment of Hypertensive Pregnancy Disorders. Guideline of DGGG (S1-Level, AWMF Registry No. 015/018, December 2013).

Authors:  H Stepan; S Kuse-Föhl; W Klockenbusch; W Rath; B Schauf; T Walther; D Schlembach
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-09       Impact factor: 2.915

5.  Plasma levels of inflammatory markers neopterin, sialic acid, and C-reactive protein in pregnancy and preeclampsia.

Authors:  Frauke M von Versen-Hoeynck; Carl A Hubel; Marcia J Gallaher; Hilary S Gammill; Robert W Powers
Journal:  Am J Hypertens       Date:  2009-03-12       Impact factor: 2.689

6.  Maternal plasma soluble TRAIL is decreased in preeclampsia.

Authors:  Piya Chaemsaithong; Tinnakorn Chaiworapongsa; Roberto Romero; Steven J Korzeniewski; Tamara Stampalija; Nandor Gabor Than; Zhong Dong; Jezid Miranda; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2013-08-13

7.  Hepatic, renal and inflammatory biomarkers are positively associated with blood pressure changes in healthy pregnant women: a prospective cohort.

Authors:  Gilberto Kac; Roberta H Mendes; Dayana R Farias; Ilana Eshriqui; Fernanda Rebelo; Camila Benaim; Ana Amélia F Vilela; Natália S Lima; Wilza A F Peres; Gil F Salles
Journal:  Medicine (Baltimore)       Date:  2015-05       Impact factor: 1.889

8.  Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases.

Authors:  Douglas B Kell
Journal:  BMC Med Genomics       Date:  2009-01-08       Impact factor: 3.063

9.  Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes.

Authors:  Henry Adekola; Roberto Romero; Piya Chaemsaithong; Steven J Korzeniewski; Zhong Dong; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2014-10-28

10.  Two variants of the C-reactive protein gene are associated with risk of pre-eclampsia in an American Indian population.

Authors:  Lyle G Best; Richa Saxena; Cindy M Anderson; Michael R Barnes; Hakon Hakonarson; Gilbert Falcon; Candelaria Martin; Berta Almoguera Castillo; Ananth Karumanchi; Kylie Keplin; Nichole Pearson; Felicia Lamb; Shellee Bercier; Brendan J Keating
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.